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Abstract
Background: Botswana is one of eight SADC countries targeting malaria elimination by 2018. Through spirited
upscaling of control activities and passive surveillance, significant reductions in case incidence of Plasmodium
falciparum (0.96 – 0.01) was achieved between 2008 and 2012. As part of the elimination campaign, active
detection of asymptomatic Plasmodium species by a highly sensitive method was deemed necessary. This study
was carried out to determine asymptomatic Plasmodium species carriage by nested PCR in the country, in 2012.
Method: A cross-sectional study involving 3924 apparently healthy participants were screened for Plasmodium
species in 14 districts (5 endemic: Okavango, Ngami, Tutume, Boteti and Bobirwa; and 9 epidemic: North East,
Francistown, Serowe-Palapye, Ghanzi, Kweneng West, Kweneng East, Kgatleng, South East, and Good Hope).
Venous blood was taken from each participant for a nested PCR detection of Plasmodium species.
Results: The parasite rates of asymptomatic Plasmodium species detected were as follows: Plasmodium falciparum,
0.16 %; Plasmodium vivax, 4.66 %; Plasmodium malariae, (Pm) 0.16 %; Plasmodium ovale, 0 %, mixed infections
(P. falciparum and P. vivax), 0.055 %; and (P. vivax and P. malariae), 0.027 %, (total: 5.062 %). The high proportion of
asymptomatic reservoir of P. vivax was clustered in the East, South Eastern and Central districts of the country.
There appeared to be a correlation between the occurrence of P. malariae infection with P. vivax infection, with
the former only occurring in districts that had substantial P. vivax circulation. The median age among 2–12 year
olds for P. vivax infection was 5 years (Mean 5.13 years, interquartile range 3–7 years). The odds of being infected
with P. vivax decreased by 7 % for each year increase in age (OR 0.93, 95 % CI 0.87–1.00, p = 0.056).
Conclusion: We have confirmed low parasite rate of asymptomatic Plasmodium species in Botswana, with the
exception of P.vivax which was unexpectedly high. This has implication for the elimination campaign so a follow
up study is warranted to inform decisions on new strategies that take this evidence into account in the elimination
campaign.
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Background
Malaria disease still kills close to half a million people an-
nually with 90 % of the deaths occurring in sub-Saharan
Africa [1]. Recently the World Health Assembly endorsed
a new Global Technical Strategy for malaria 2016–2030,
which included reducing the case incidence and mortality
of malaria by 90 % and target elimination in 35 countries
[2]. Botswana is one of eight Southern Africa Developing
Countries (SADC) targeting malaria elimination by 2018,
[3] after achieving significant reduction in case incidence
(0.97-0.01) from 2008 to 2012 [4, 5], attributed to a spir-
ited upscaling of interventional activities. Malaria control
activities in the country began in the 1950s with a focus
on vector control. A change in focus from 2008 which in-
cluded passive surveillance through monthly reports and
integrated disease surveillance and reports, enabled attain-
ment of targets for the adoption of malaria elimination
strategy in 2009 (Botswana Ministry of Health, MIS, 2012,
WHO world malaria report).
In general the trend in transmission in Botswana is sea-
sonal and unstable ranging from high endemicity in the
northern part of the country to very low in the southern
part of the country (Fig. 1). This largely, depends on rain-
fall patterns and temperature [4, 6]. The northern part ex-
periences relatively high rainfall in the summer and
relatively mild winter temperatures. In contrast, the south-
ern part of the country experiences relatively low rainfall
in the summer and relatively low winter temperatures.
Out of the five different species of the genus Plasmodium
known to infect humans, (Plasmodium falciparum: Pf,
Plasmodium vivax: Pv, Plasmodium ovale, Plasmodium
malariae and Plasmodium knowlesi) Pf infection is the
major known cause in Botswana. It is estimated that 98 %
of malaria infections are Pf, while 2 % is attributed to Pv
[4]. The human parasite reservoir is made up of symptom-
atic and asymptomatic individuals. The latter is recog-
nized to constitute a significant proportion of the parasite
reservoir and serve as a significant source of transmission
Fig. 1 Map of malaria endemicity in Botswana). The Map was obtained from the Botswana NMCP
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[7–9] as the individuals do not seek health care. For an
elimination strategy to be successful, it is crucial that
asymptomatic and submicroscopic reservoirs of Plasmo-
dium species are sought out actively for targeted
intervention. It is also well established that in malaria
elimination countries, as Pf incidence rate goes down Pv
incidence rate increases [10], because of the unique bio-
logical characteristics of the parasite. These include dor-
mant liver stage that results in relapses even after
treatment, development in mosquito vectors at lower am-
bient temperatures and therefore has a large span of eco-
logically induced infectivity, and its lower parasite density
that limits detection microscopically and by RDT. Clearly
for an elimination strategy, highly sensitive methods of
detection are also required [11, 12]. As part of the malaria
elimination strategy in Botswana, the first active surveil-
lance of asymptomatic Plasmodium spp was undertaken
in 2012. This was carried out throughout all defined zones
of endemicity in the country, using PCR methodology for
the case detection. The choice of PCR methodology was
informed by the fact that it is well recognized that PCR
consistently detects at least twice as many infections as
light microscopy and therefore an excellent choice when
high sensitivity is desired [13, 14]. The work was under-
taken to provide guidance in interventional activities
towards focal areas of transmission especially for asymp-
tomatic individuals, so that informed decisions on new
strategies towards the malaria elimination agenda are
made. The present article presents the findings.
Method
Study Site
Study sites were selected with the support of Statistics
Botswana from five endemic and nine non-endemic dis-
tricts in Botswana. These were respectively, Okavango,
Ngami, Tutume, Boteti and Bobirwa (Endemic areas),
and North East, Francistown, Serowe-Palapye, Ghanzi,
Kweneng West, Kweneng East, Kgatleng, South East,
and Good Hope (epidemic areas) (Fig. 1). Within each
district, the Ministry of education primary school regis-
ter and Ministry of Health Clinic/Health post registers
were used to randomly select the schools and clinics
from which enrolment was done.
Study subjects and blood sample collection
The study included 3624 subjects of ages 2–12 enrolled
within a month in May 2012, in the identified catchment
area schools, welfare clinics and healthposts, using a
multistage sampling strategy. The first stage was a pur-
poseful selection of districts with known malaria trans-
mission, classified as either highly endemic, moderate,
low or sporadic, based on recommendations from the
National Malaria Control Program (NMCP). In the
second stage which was also purposeful, towns within
the districts that constituted the focal areas of transmis-
sion were selected based on NMCP recommendation,
using guidelines on classification of malaria transmission
endemicity. This was to ensure that areas of high,
moderate, low and sporadic transmissions with distinct
characteristics in each community were captured in the
sampling process. In the third stage, schools/clinics
within each town were purposefully selected using a two
stage clustering approach based on population density
and adequate cross sectional representation of the com-
munities to avoid any bias. In the final stage, participants
were assigned numbers and randomly enrolled following
informed parental consent and consent of heads of
schools and clinics. The total number of samples ob-
tained per district/town was directly proportional to the
estimated population. The formula used in calculating
the sample size was: n = (z2)(r)(1-r)(f )(k)/(p)(ñ)(e2). Using
an estimated Pv known prevalence for Africa (r) of
10 %); z statistic of 1.96 for the 95 % Confidence Inter-
val, design effect (f ) of 2.4; non response rate (k) of 8 %;
the proportion of the population under 12 (p) of 0.34;
average household size (ñ)of 3.4; and margin of error (e)
of 8 %; a sample size of 897 households was obtained
from which the total number of samples were derived
based on the population of the districts. Children aged
6–12 years were largely from the primary schools while
those aged from 2 to 5 were enrolled from the child
welfare clinics and health posts. The subjects from
the clinics did not present with any disease except
normal growth monitoring follow up visits. All the
enrolled children were asymptomatic for malaria.
Asymptomatic subjects were individuals with body
temperatures <37.5 °C at the time of sample collec-
tion and without a history of fever in the preceding
72 h. A subject was enrolled if the individual had no
complaints related to malaria, had not left the village
for a year at least and parental consent was given for
blood to be taken. The sample collection was timed
to coincide with the onset and peak of the malaria
season in the country.
After consent from the guardian or parent of the
subjects, a short clinical assessment of tympanic
temperature was done and history of malaria and travel
requested. Subsequently, basic demographic information
on age and sex was documented. A 2.5 to 3 ml venous
blood was collected into EDTA vacutainer tubes from
which three Dried Blood Spots (DBS) were made unto
whatman number 3 filter papers enclosed in zip lock
bags with desiccators each. Samples were stored in ice
packs (DBS papers were retained at room temperature)
and transported to the laboratory within 30 min. Blood
was separated by centrifugation into plasma and cell pel-
lets which were frozen at -20 °C and subsequently -80 °C
till analyzed.
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Laboratory analysis
DNA extraction
Genomic DNA (gDNA) was isolated from red blood cell
pellets (100 μl, corresponding to 200 μl of whole blood)
using the QiaAmp DNA Blood mini kit (Qiagen Inc., Val-
encia, CA) or Quick-gDNA™ Blood Mini Prep (Zymo Re-
search, USA) and quantified with the Fisher Thermo
Scientific Nanodrop 2000/2000C USA. All DNA were
eluted into 100 μl elution buffer and stored at -80 °C till
used for PCR.
Molecular detection of Plasmodium species
All Plasmodium species were detected by a slight modi-
fication (with respect to the amount of DNA used in
the reactions, total volume of PCR reactions, type and
quantity of DNA polymerase used and cycling condi-
tions) of the double nested PCR procedure targeting
conserved species specific regions of the small subunit
18S ribosomal RNA (18S ssRNA) [15]. The first nested
reaction was genus specific, and if positive, was
followed by a species specific nested reaction. All detec-
tion assays were single-plexed and run in a 96 well
plate Roche light cycler platform. The PCR kits were
the Qiagen PCR core kit (Qiagen Inc, Valencia, CA).
Species specific primers were ordered from Eurogentec,
Liege, Belgium and control Plasmodium species DNA,
from ATCC, Virginia, USA. The primer sequences were
exactly as published previously [15].
All amplification reactions were carried out in a total
volume of 25 μl and in the presence of 10 mM Tris-
HCl, pH 8.3, 4 mM MgCl2, 50 mM KCl, 250nM of each
oligonucleotide primer, 200 μM of each of the four
dNTPs and 0.5 units of Dream Taq DNA polymerase.
5 μl of DNA prepared from whole blood was used to ini-
tiate the genus specific primary amplification PCR reac-
tion and 2 μl of the product was then used in the
secondary amplification including the species specific
detection assays. The PCR cycling parameters for the
primary amplification were as follows: initial denatur-
ation at 94 °C for 10mins, preceded the cyclin conditions
which consisted of denaturation at 94 °C for 30 s, an-
nealing at 55 °C for 1 min and extension at 72 °C for
1 min for 35 cycles. After the final annealing step
followed by extension at 72 °C for four minutes, the re-
action was ended. In the second nested PCR, annealing
temperature of 62 °C was used. For the species specific
amplifications the only changes were initial denaturation
at 94 °C for four mins and annealing at 58 °C.
To ensure that there was no cross contamination,
negative control samples (no DNA template) were
randomly included in the run. The consistency of
the results was checked by multiple runs of a num-
ber of subsets of the samples which were randomly
picked.
The amplified products were analyzed on 2 % agarose
gels by electrophoresis, followed by visualization on a
UV transilluminator after ethidium bromide staining.
Statistical analysis
Data were entered into an Excel data sheet and used in
SPSS and STATA v11.2 (StataCorp, College Station, TX,
USA) for analysis. Descriptive statistics were provided for
relevant demographic covariates. Comparisons of categor-
ical variables were done with chi-square testing or Fisher’s
exact test. Factors influencing the likelihood of malaria in-




A total of 3624 children across 14 districts were assessed
for Plasmodium species. The mean age of all enrolled sub-
jects was 5.48, which was distributed as follows: <2 years,
0.084 %; 2- < 5, 41 %; 5- < 9, 47.27 %; >9 years, 11.65 %;
while gender was 51.1 % female. None of the participants
had traveled outside the country for the past year.
Prevalence of Plasmodium species
Overall 4.99 % of individuals had Plasmodium species in-
fection segregated as follows: Pf, 0.16 %; Pv, 4.66 %; P.
malariae (Pm), 0.16 %; P. ovale, 0 %, mixed infections (Pf
and Pv), 0.055 %; and (Pv and Pm), 0.027 %. Pv infection
accounted for 93.37 % of the Plasmodium species infec-
tion in the population. The distribution of Plasmodium
species infection by district is shown in Table 1. The Pv
infection was clustered around East (Tutume, Francis-
town), South East (Serowe-Palapye and South East) and
Central districts (Kweneng East) (Fig. 2). These areas of
Pv infections do not correlate geographically with Pf infec-
tions in the established zones of endemicity, however they
overlap partially with newly identified hotspots in the
country. We noted from the NMCP that the indicated
areas have a higher proportion of migrants who may carry
latent infections. The odds that a child resident would be
infected with Pv species was 9.19 times higher (95 % CI
5.50–15.4, p < 0.001) in the Tutume region and 7.10 times
higher (95 % CI 4.41–11.4, p < 0.001) in the Kweneng East
region than in the rest of the districts that had detectable
Pv infection. The median age of those infected with Pv
was 5 years (Mean 5.13 years, interquartile range 3–7
years) while those not infected with any species of Plasmo-
dium had a median age of 6 years (mean 5.50 years, Inter-
quartile range 3–8 years). The age breakdown for those
infected with Pv was: <5 years, 72 positives from 1466
specimens (4.91 %); 5- < 9 years, 65 positives from 1688
specimens (3.85 %); 9–12 years, 16 positives from 416
specimens (3.85 %). These differences in positivity be-
tween age categories were not statistically significant.
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However, the odds of being infected with Pv decreased by
7 % for each year increase in age (OR 0.93, 95 % CI 0.87–
1.00, p = 0.056). Districts with higher numbers of Pv infec-
tions appeared to have higher numbers of Pm infections
as well; Pm infections were only detected in the district
with the most Pv transmissions (Kweneng East), the
second-most Pv infections (Tutume), and the Francistown
district. We did not encounter any problem with contam-
ination of samples.
Discussion
The Botswana malaria elimination program has clearly
been on track as the asymptomatic Pf reservoir deter-
mined in this study is only 0.16 %. However, our identifi-
cation for the first time of a significant asymptomatic Pv
reservoir in the country has brought in a new paradigm
for the elimination program that requires immediate at-
tention, in order to sustain the gains made to date and
achieve the new target of elimination by 2018. Our find-
ings add to the growing evidence of the presence of Pv
in Africa. As has been observed in other countries, the
reservoir of Pv was clustered, [16, 17] centering in
Tutume and Kweneng East as major hotspots with
minor hotspots to the East and South Eastern districts.
It is not clear to us at the moment why the infection
was clustered in the identified hotspots, except that the
communities have a “rural” setting as have been ob-
served elsewhere [16]. In addition we learnt from the
NMCP that a significant number of the inhabitants in
these areas are migrant workers so it is probable that in
some time past they may have travelled and harbored
hypnozoites. Liu et al [18] recently suggested that in
populations of high Duffy negativity, one probable
source of infection will be zoonotic, with the primary
source being ape reservoirs. The transmission between
apes and humans is reported to be facilitated by An.
moucheti and An. vinckei [18–20]. We observed that the
age of the population group at risk was localized largely
within the 5–7 year olds, with the odds decreasing with
increasing age. This is in consonance with similar obser-
vations in Ethiopia and Peru [17, 21]. It has been argued
that the population group that has the highest probable
exposure to competent vectors is at the most risk of in-
fection. In this regard a recent article from Botswana
covering the period from 2012 to 2014, reported that the
age group greater than 14 years had the highest number
of malaria cases detected by RDT [22]. It appears that
the rigorous indoor spraying and education on the use
of insecticide treated bed nets by the NMCP, is impact-
ing on indoor feeding of vectors and causing a shift in
the vulnerable population group in the country. There is
an evident need for further interrogation of factors that
drive Pv transmission within specified populations in
Botswana and sub-Saharan Africa.
The role of Pv in malaria transmission and elimination
in sub-Saharan Africa is increasingly drawing attention.
Infection of rbcs by Pv is traditionally established to be
attributed to positivity for the Duffy antigen, also called
Duffy antigen receptor for chemokines (DARC) [23–25].
A significant number of the population in Africa has a
null phenotype so that transmission of Pv is considered
an unlikely scenario. However, past and recent reports
from several countries in sub-Saharan Africa, including
Liberia, Senegal, Equitorial Guinea, Angola, Ethiopia,
Cameroon, Kenya and Malagasy, have shown that Duffy
negativity alone does not preclude infection with Pv
[26–31]. The Duffy negativity rate in Southern Africa in-
cluding Botswana is estimated between 0 and 30 % [24],
so the findings are of particular interest, regarding the
Duffy positivity rate in the affected population. It may
also be that some environmental factor is driving the in-
fection of Duffy null erythrocytes through a yet to be
identified receptor. It is interesting that from a recent
map of Duffy negativity in Botswana, the most negative
population is in the Eastern sector where the cluster of
Pv infections were found [16]. Further efforts at probing
into potential mechanisms of Pv infection, may first be
focused on host characteristics within the populations
including the environment, parasite genetic variability
and available competent vectors. Recently a report on
modeling of Pv infection dynamics revealed that up to
90–96 % of Pv infection in endemic areas is due to hyp-
nozoite reactivation [32]. A major factor that has been
suggested to induce reactivation is host stress factors
Table 1 The distribution of asymptomatic Plasmodium species
infection by district
District(n) Plasmodium species
P. falciparum (Pf) P. vivax (Pv) P. malariae (Pm)
Okavango(208) 1 1 0
Ngami(80) 1 1 0
Tutume(320) 0 54 2
Boteti(181) 0 0 0
Bobirwa(203) 0 0 0
North East(160) 0 0 0
Francistown(195) 0 4 1
Serowe-Palapye(361) 1 11 0
Ghanzi(163) 0 0 0
Kweneng West(375) 1 0 0
Kweneng East(687) 0 93 3
Kgatleng(358) 0 0 0
South East(174) 0 5 0
Good Hope(159) 0 0 0
Total (3624) 4 169a 6
aThe odds of being infected with Pv decreased by 7 % for each year increase
in age (OR 0.93, 95%CI 0.87–1.00, p = 0.056)
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(eg, infectious disease exposure) [33, 34]. We observed
an apparent correlation between Pm infection and Pv in-
fection in this study (though the lack of Pm cases pre-
cludes the demonstration of a statistically significant
association) but as to whether they play complimentary
roles in infectivity requires further interrogation. Pv ap-
pears to show high clonal diversity in endemic regions,
so that genotyping approaches will also be necessary in
elucidation of the infection dynamics.
Our findings also highlight the fact that active case de-
tection (ACD) in malaria elimination is crucial in the
identification of hotspots. ACD is expensive so malaria
elimination programs need to think through appropriate
models that are cost effective. Two suggested models are
reactive case detection and proactive case detection. In a
reactive case detection model, a trigger of a passive case
leads to the screening of households including neighbors
[35]. The limitation in this case is defining the number
of neighboring households that form a critical threshold
for screening. In a proactive case detection, known or
recognized hotspots are screened periodically in the
absence of any trigger, passively. In adopting an appro-
priate strategy, neighboring countries within the SADC
E8 need to engage in active conversation and adopt feas-
ible and common strategies so that baseline factors on
specific models can be developed and shared.
Conclusions
We have provided molecular evidence for the first time
of Pv asymptomatic infection in Botswana and also af-
firmed that the malaria control program targeting Pf has
indeed been on track. New and concerted strategies to
achieve elimination of malaria in 2018 in Botswana are
urgently required as are efforts at better understanding
of characteristics of susceptible host, environmental fac-
tors and Pv biological characteristics.
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